GlassScriptPhysician profile
David L Toups
NPI 1992738827
$1,203.78
in general payments reported to CMS, 2019-2025
8 companies · $235 in 2025
The $235 reported for 2025 was more than what 85% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.51 · 2020: $131 · 2021: $216 · 2022: $198 · 2023: $175 · 2024: $172 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $582.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $582.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $478.99 | 2019-2024 | Xarelto |
| Inari Medical, INC. | $287.80 | 2021-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Axsome Therapeutics, INC. | $234.57 | 2025 | Sunosi |
| Jazz Pharmaceuticals INC. | $98.03 | 2020 | |
| Ethicon US, LLC | $41.73 | 2024 | Surgicel Nu-Knit, Dermabond Prineo, Stratafix |
| Abbvie INC. | $29.59 | 2022-2024 | |
| Fisher & Paykel Healthcare INC | $19.96 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $13.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Toups listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.